Description

Klinik Psikofarmakoloji Bülteni- Bulletin of Clinical Psychopharmacology (hereafter referred to as The Bulletin of Clinical Psychopharmacology) has published peer-reviewed English and Turkish written articles four times a year since 1990.  Topics of current interest to clinical, experimental and basic scientists are published in critical subjects such as psychopharmacology, psychiatry and behavioral science.

The Bulletin of Clinical Psychopharmacology has a target audience of specialists, residents and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry and related sciences. 

General Policies 

The Bulletin of Clinical Psychopharmacology will consider for publication papers in the following categories: 

- Original Research

- Case reports

- Reviews. 

The Bulletin of Clinical Psychopharmacology accepts articles from researchers throughout the world; however, high priority is given to publishing original studies with the aim of sharing Turkish research findings with, and introducing Turkish scientists to, the international scientific community.

Articles in both English and Turkish are accepted; however, authors are requested to provide their abstracts in both English and Turkish, if possible, so that readers may access the abstract in both languages. 

AUTHORSHIP AND RESPONSIBILITY 

By submitting a manuscript to The Bulletin of Clinical Psychopharmacology, all persons named as authors warrant that they have reviewed and approved the manuscript prior to submission, and that they accept responsibility for the information contained in the submission. Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. Authors should meet conditions 1, 2, and 3. In multicentre studies, the individuals should fully meet the criteria for authorship/contributorship defined above and editors will ask these individuals to complete journal-specific author and conflict-of-interest disclosure forms. All authors must sign a copyright transfer form. The names and surnames of all authors must be placed under the title of the manuscript. Individuals who were not principal researchers or writers should not be listed as authors, but should be acknowledged instead for their ancillary role in an acknowledgment footnote. By submitting original research, the authors warrant that the original research data are available for review upon a formal request from the Editor.  

All forms of support, including pharmaceutical industry support, must be acknowledged in the author's footnote (see "Acknowledgments" below, in the Title Page section). Also, authors must disclose in their cover letter any commercial or financial involvements that might present an appearance of a conflict of interest in connection with the submitted article, including (but not limited to) institutional or corporate affiliations not already specified in the author's footnote, paid consultancies, stock ownership or other equity interests, and patent ownership. This information will be kept confidential and will not be shared with reviewers. 

ETHICAL CONSIDERATIONS 

When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 2000. Manuscripts that report the results of experimental investigation with human subjects must include a statement that informed consent was obtained after the procedure(s) had been fully explained. In the case of children, authors are asked to include information about whether the child's assent was obtained in addition to that of the legal guardian. In addition, the consent of a local or national ethics committee has to be sent with the manuscript. When reporting experiments on animals, authors should indicate whether the institutional and national guides for the care and use of laboratory animals were followed as in "Guide for the Care and Use of Laboratory Animals" (www.nap.edu/catalog/5140.html). The authors must mention in the methods section of the manuscript that they had performed the study in accordance with above-mentioned rules and, in the case of humans, emphasize that they had received informed consent from the participants.

The Bulletin of Clinical Psychopharmacology will only publish papers with the highest ethical and scientific standards and is not influenced by commercial interests. 

The Editor and Publisher do not guarantee or accept responsibility for the published features or definitions of commercial products. If there is direct or indirect grant support, it should be acknowledged in a separate paragraph and should include the full name of the granting agency and grant number.  Pharmaceutical company or other industry support of any kind must be acknowledged. 

Ethical as well as legal considerations require careful attention to the protection of a patient's anonymity in case reports and elsewhere. Identifying information such as names, initials, hospital numbers, dates, photographs, and family pedigree must be avoided. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be published. Patient consent should be written and archived either with the journal, the authors, or both, as dictated by local regulations or laws. It must be mentioned in the text that informed consent was obtained from the participants.  

EDITORSHIP AND THE RELATIONSHIP WITH AUTHORS AND REVIEWERS 

The editor of the journal is the person responsible for its entire content. The editor does not share information about manuscripts (submission, contents, reviewing process, reviewers’ suggestions or publishing decisions) with anyone other than the authors or reviewers. 

The editor informs the reviewers that the manuscripts are confidential information and that this is a privileged interaction. The reviewers and editorial board cannot discuss the manuscripts with other persons. The reviewers are not allowed to have copies of the manuscripts for personal use and they can not share manuscripts with others. Unless the authors and editor permit, the reviews cannot be published or disclosed. The anonymity of the reviewers is important. In particular situations, the editor may share the review of one reviewer with other reviewers to clarify a particular point. 

LANGUAGE 

The language of the journal is both Turkish and English (United States). 

MANUSCRIPT ORGANIZATION AND FORMAT 

All correspondence will be sent to the first-named author unless otherwise specified. Papers should be accompanied by a cover letter indicating that the paper is intended for publication and specifying for which section of the Journal it is being submitted (i.e., original article, review article, or case report). In addition, a copyright transfer that has to be signed by all authors should be submitted. Authors will be notified of the receipt of their paper and the number assigned to it. The number should be included in all further correspondence. 

All parts of the manuscript, including case reports, quotations, references, and tables, must be double-spaced throughout. All four margins must be at least 2.5 cm. The manuscript should be arranged in the following order, with each item beginning a new page: 1) title page, 2) abstract, 3) text, 4) acknowledgment 5) references, and 6) tables and/or figures. All pages must be numbered consecutively. 

Title Page 

On the title page, include full names of authors, academic or professional affiliations, and complete addresses with phone numbers, fax number(s) and e-mail address(es) of the corresponding author. Acknowledgments for personal and technical assistance should be indicated on the title page. 

Abstract and key words 

Title of the manuscript in English should be written in the English abstract. The abstract should be no shorter than 400 and no longer than 500 words and structured as follows: objectives, methods, results, and conclusions. 

Objective(s) -the primary purpose of the article; Method(s) -data sources, design of the study, patients or participants, interventions, and main outcome measures; Results -key findings; Conclusions -including direct clinical applications. Case reports should include unstructured abstracts. 

Up to 3-10 key words should be provided, in accordance with Index Medicus, Medical Subjects Subheadings (MeSH). 

Introduction  

This section should contain a clear statement of the general and specific objectives of the study, as well as the hypotheses that the work is designed to test. It should also give a brief account of the reported literature. The last sentence should clearly state the primary and secondary purposes of the article. References related to the issues raised must be indicated. Data or findings from the current study must not be included in this section. 

Methods  

This section should contain explicit, concise descriptions of all procedures, materials and methods used in the investigation to enable the reader to judge their accuracy, reproducibility, etc. This section should include the known findings at the beginning of the study. Findings from the current study must be reported in the results section. 

The selection and description of the participants  

The selection, population source, inclusion and exclusion criteria of the subjects who participated in experimental or clinical studies must be clearly defined in this section. The particular study sample must be explained by the authors (i.e., why the study was performed in a definite age, race or sex population, etc.) 

Technical information

The methods, apparatus (the manufacturer's name and address in parentheses), and procedures must be described in sufficient detail to allow others to reproduce the results. References to established methods, including statistical methods (see below) must be given. Brief descriptions for methods that have been published but are not well known must be provided.  New or substantially modified methods must be described, the reasons for using them must be given, and the limitations of the methods must be evaluated. All drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration must be identified.

 Authors submitting review manuscripts should include a section describing the methods used for locating, selecting, extracting, and synthesizing data. These methods should also be summarized in the abstract.

 Statistics

 The statistical methods must be described with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. If possible, findings should be quantified and presented with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Relying solely on statistical hypothesis testing, such as P values, which fail to convey important information about effect size must be avoided. References for the design of the study and statistical methods should be to standard works when possible (with pages stated). Define statistical terms, abbreviations, and most symbols. The computer software used must be specified.

 Results

 The results should be presented in logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Data in the tables or illustrations should not be repeated in the text; only the most important observations should be emphasized or summarized in the text. Extra or supplementary materials and technical detail can be placed in an appendix where they will be accessible but will not interrupt the flow of the text, or they can be published solely in the electronic version of the journal.

 When data are summarized in the Results section, numeric results should be given not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and the statistical methods used to analyze them should be specified. Restrict tables and figures to those needed to explain the argument of the paper and to assess supporting data. Graphs should be used as an alternative to tables with many entries; data should not be duplicated in graphs and tables.

 Discussion

 The findings of the study which support or do not support the hypothesis of the study should be discussed, results should be compared and contrasted with findings of other studies in the literature and the differences from other studies should be explained. The new and important aspects of the study and the conclusions that follow from them should be emphasized. The data or other information given in the Introduction or the Results section should not be repeated in detail. For experimental studies, it is useful to begin the discussion by summarizing briefly the main findings, then explore possible mechanisms or explanations for these findings, compare and contrast the results with other relevant studies, state the limitations of the study, and explore the implications of the findings for future research and for clinical practice.

 The conclusions should be linked with the goals of the study but unqualified statements and conclusions not adequately supported by the data should be avoided. New hypotheses should be stated when warranted, but should be labeled clearly as such.

 Tables, graphics and illustrations:

 Tables, graphics and illustrations should be numbered in Arabic numerals in the text. The placement of the illustrations should be indicated in the text.

 Tables  

Tables capture information concisely and display it efficiently; they also provide information at any desired level of detail and precision. Including data in tables rather than text frequently makes it possible to reduce the length of the text.

 Each table should be typed or printed with double spacing on a separate sheet of paper. The tables should be numbered consecutively in the order of their first citation in the text and a brief title for each table should be supplied. Internal horizontal or vertical lines should not be used. A short or an abbreviated heading should be given to each column. Authors should place explanatory matter in footnotes, not in the heading. All nonstandard abbreviations should be explained in footnotes, and the following symbols should be used in sequence:

 *,†,‡,§,||,¶,**,††,‡‡

 The statistical measures of variations, such as standard deviation and standard error of the mean, should be identified. Be sure that each table is cited in the text. If you use data from another published or unpublished source, obtain permission and acknowledge that source fully.

 Additional tables containing backup data too extensive to publish in print may be appropriate for publication in the electronic version of the journal, deposited with an archival service, or made available to readers directly by the authors. An appropriate statement should be added to the text. Such tables should be submitted for consideration with the paper so that they will be available to the peer reviewers.

 Illustrations (Figures)

 Figures should be either professionally drawn and photographed, or submitted as digital prints in photographic-quality. In addition to providing a version of the figures suitable for printing, authors are asked for electronic files of figures in a format (for example, JPEG or GIF) that will produce high-quality images in the Web version of the journal. Authors should review the images of such files on a computer screen before submitting them to be sure that they meet their own quality standards.

 For x-ray films, scans, and other diagnostic images, as well as pictures of pathology specimens or photomicrographs, sharp, glossy, black-and-white or color photographic prints should be sent, usually 127 x 173 mm. Letters, numbers, and symbols on figures should therefore be clear and consistent throughout, and large enough to remain legible when the figure is reduced for publication. Figures should be made as self-explanatory as possible, since many will be used directly in slide presentations. Titles and detailed explanations belong in the legends--not on the illustrations themselves. Photomicrographs should have internal scale markers. Symbols, arrows, or letters used in photomicrographs should contrast with the background. Photographs of potentially identifiable people must be accompanied by written permission to use the photograph.

 Figures should be numbered consecutively according to the order in which they have been cited in the text. If a figure has been published previously, the original source should be acknowledged and written permission from the copyright holder should be submitted to reproduce the figure. Permission is required irrespective of authorship or publisher except for documents in the public domain.

 Accompanying drawings marked to indicate the region to be reproduced might be useful to the editor. We publish illustrations in color only if the author pays the additional cost.

 Legends for Illustrations (Figures)

 The legends for illustrations should be typed or printed using single spacing, starting on a separate page, with Arabic numerals corresponding to the illustrations. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, each one should be identified clearly and explained in the legend. The internal scale should be explained and the method of staining in photomicrographs should be identified.

 Units of Measurement

 Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter) or their decimal multiples. Temperatures should be in degrees Celsius, blood pressures should be in millimeters of mercury.

 Authors should report laboratory information in both local and the International System of Units (SI). Drug concentrations may be reported in either SI or mass units, but the alternative should be provided in parentheses where appropriate.

 Abbreviations and Symbols

 Use only standard abbreviations; use of nonstandard abbreviations can be confusing to readers. Avoid abbreviations in the title of the manuscript. The spelled-out abbreviation followed by the abbreviation in parenthesis should be used on first mention unless the abbreviation is a standard unit of measurement.

 Case Reports and word limitation

 Original papers and reviews have no specific word limitation. A case report must be strictly limited to 1000 words, excluding the abstract, and have minimal figures, tables, and references. Letters to the Editor (maximum of 500 words, including references; no tables or figures) will be considered if they include the notation "for publication." A letter must be signed by all of its authors. Letters critical of an article published in the journal must be received within 12 weeks of the publication of the original article.

 Acknowledgments

 All forms of support, including individual technical support or material support must be acknowledged in the author's footnote before the references.

 References

 Although references to review articles can be an efficient way to guide readers to a body of literature, review articles do not always reflect original work accurately. Readers should therefore be provided with direct references to original research sources whenever possible. On the other hand, extensive lists of references to original work on a topic can use excessive space on the printed page. Small numbers of references to key original papers often serve as well as more exhaustive lists, particularly since references can now be added to the electronic version of published papers, and since electronic literature searching allows readers to retrieve published literature efficiently.

 Using abstracts as references should be avoided. References to papers accepted but not yet published should be designated as "in press" or "forthcoming"; authors should obtain written permission to cite such papers as well as verification that they have been accepted for publication. Information from manuscripts submitted but not accepted should be cited in the text as "unpublished observations" with written permission from the source.

 Citing a "personal communication" should be avoided unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text. For scientific articles, written permission and confirmation of accuracy from the source of a personal communication must be obtained.

Reference Style and Format

 The Uniform Requirements style for references is based largely on an American National Standards Institute style adapted by the NLM for its databases. Authors should consult NLM's Citing Medicine (http://www.nlm.nih.gov/bsd/uniform_requirements.html) for information on its recommended formats for a variety of reference types.

 References should be numbered consecutively in the order in which they are first mentioned in the text. Identify references in text, tables, and legends by Arabic numerals in parentheses. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure. The titles of journals should be abbreviated according to the style used in the list of Journals in Index Medicus. In addition, the list may be obtained on the website at http://www.nlm.nih.gov.

 Accuracy of citation is the author's responsibility. All references should be cited in the text.

References should be provided in the style shown below. List all authors; do not use "et al.".  Abbreviations of journal names should conform to the style used in Index Medicus. If a journal is not indexed in Index Medicus, it should not be abbreviated.

 Examples of references:

 1. For articles from a journal:

 Originally published in a journal indexed and abbreviated in Medline:

Czubak A, Nowakowska E, Kus K, Burda K, Metelska J, Baer-Dubowska W, Cichocki M. Influences of chronic venlafaxine, olanzapine and nicotine on the hippocampal and cortical concentrations of brain-derived neurotrophic factor (BDNF). Pharmacol Rep. 2009;61:1017-23. 

Kennedy SH, Rizvi SJ.Agomelatine in the Treatment of Major Depressive Disorder: Potential for Clinical Effectiveness.CNS Drugs. 2010 Mar 1. doi: 10.2165/11534420-000000000-00000.

 Originally published in a journal not indexed and abbreviated in Medline:

Cetin M, Acikel C: In perspective of meta-analyses: Are all of the antidepressants similar? Klinik Psikofarmakoloji Bülteni- Bulletin of Clinical Psychopharmacology 2009; 19:87-92. (Turkish)

 2. For articles from a supplement:

Originally published in a journal indexed and abbreviated in Medline:

Wasylenski DA. The cost of schizophrenia. Can J Psychiatry 1994; 39 (Suppl.2): S65-S69.

 Originally published in a journal not indexed and abbreviated in Medline:  

Karamustafalioglu O: What are treatment response and remission in the treatment of depression? How are they measured? Klinik Psikofarmakoloji Bülteni- Bulletin of Clinical Psychopharmacology 2010;20: ( Ek sayı-Suppl.1):S 16- S21.( Turkish)

 3. For articles in press:  

Littlewhite HB, Donald JA. Pulmonary blood flow regulation in an aquatic snake. Science 2002 (in press)

 4. For citations from books:  

Books edited by one editor:

Dogan O. Davranis Bilimleri. 2. Baski, Sivas: Önder Matbaasi, 1999: 41-49.   

For a citation from a section of a book edited by one editor:

Mc Nab S. Lacrimal surgery.In Willshaw H (editor). Practical Ophthalmic Surgery. New York: Churchill Livingstone Inc, 1992: 191-211. 

For a citation from a section of a book edited by more than one editor:

Taylor R. Depression and gynaecological disorders. In Textbook of Gynaecology, Robertson MM, Katona CLE (editors). First ed., New York: John Wiley & Sons, 1997: 133-144. 

If the authors of the cited section are the editors of the book:

Diener HC, Wilkinson M (editors). Drug-induced headache. In Headache. Flst ed., New York: Springer-Verlag, 1988: 45-67.

 For a citation from a translated book:

Milkman HB, Sederer LI. Alkolizm ve Madde Bagimliliginda Tedavi Seçenekleri. Dogan Y, Özden A, Izmir M (Translators) 1. Baski, Ankara: Ankara Üniversitesi Basimevi, 1994: 79-96. 

5. For citations from a thesis:

Kiliç C. Genel Saglik Anketi: Güvenirlik ve Geçerlilik Çalismasi. Yayinlanmamis Uzmanlik Tezi, Hacettepe Üniversitesi Tip Fakültesi, Psikiyatri AD, Ankara: 1992 

6. For a citation from a poster:

Felek S, Kiliç SS, Akbulut A, Yildiz M. Görsel halüsinasyonla seyreden bir fligelloz olgusu. XXVI. Türk Mikrobiyoloji Kongresi Özet Kitabi, 22-27 Eylül 2000, Antalya

SUBMISSION TO THE JOURNAL:  

All new manuscripts must be submitted through the Bulletin of Clinical Psychopharmacology online manuscript submission and peer review system (www.psikofarmakoloji.org). Complete instructions are available on the website.  

A cover letter should accompany the manuscript including an acknowledgment that:

• The findings of the same or a similar study have been previously published.  Copies of such studies should be sent with the submitted manuscript to assist in the editorial process.

• All authors have read and accepted the study in its final form and all authors meet the criteria for authorship

• Anything that may assist the editor in making his decision should be stated. The comments of previous editors/reviewers and the response of authors should be added if the manuscript has been previously sent to another journal for consideration. The editor requests this information to accelerate the publication process.

• The authors are kindly requested to consult the Submission Checklist (see below) before submission.

 Address for manuscript submission (for authors without internet access)  

Prof. Dr. Mesut ÇETIN,

Bagdat Caddesi No: 453/3 Suadiye 34074 Istanbul

Ph: +90 (216) 464 2888 - 384 5476

Ph - Fax: +90 (216) 464 5724 - 349 3517

Mobile telephone (GSM): +90 (532) 272 3252

Electronic mail address: psikofarmakoloji@gmail.com or mesutcetin@yahoo.com

 Submission Checklist:

 It is hoped that this list will be useful during the final checking of an article prior to sending it to the journal's editor for review. Please consult the Information for Authors for further details of any item.

 Ensure that the following items are present:

• Cover letter to the editor

• The category of the manuscript

• Acknowledgment that "the paper is not under consideration for publication in another journal"

• Disclosure of any commercial or financial involvement

• Copyright transfer form

• Permission for use of previously published material if used in the present manuscript

• Acknowledgment that the study was conducted "in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 2000.

• Statement that informed consent was obtained from all subjects after the procedure(s) had been fully explained.

• Indication of whether the institutional and national guide for the care and use of laboratory animals was followed as in "Guide for the Care and Use of Laboratory Animals".

• Title page

• The title of the manuscript both in Turkish and in English

• All authors and affiliations (e-mail address, full postal address, telephone and fax numbers)

• Abstracts (400-500 words), both in Turkish and in English

• Key words: 3 to 10 words (in Turkish and in English)

• Acknowledgment(s)

• References

• All tables (including title, description, footnotes)

 Also please review the statistical design of the research article and do a final check for fluent English.